These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31282108)
1. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma. Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. Wang Z; Shi Y; Ying C; Jiang Y; Hu J Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370 [TBL] [Abstract][Full Text] [Related]
3. Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma. Gao Y; Liu B; Feng L; Sun B; He S; Yang Y; Wu G; E G; Liu C; Gao Y; Zhang E; Zhu B Front Oncol; 2019; 9():33. PubMed ID: 30775317 [TBL] [Abstract][Full Text] [Related]
4. Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect? El-Tohamy R; Elkholi I; Elsherbiny ME; Magdy M; Hammam O; Allalunis-Turner J; Emara M Oncol Rep; 2020 Mar; 43(3):975-985. PubMed ID: 32020230 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
6. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis. Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG Front Immunol; 2020; 11():1281. PubMed ID: 32765489 [No Abstract] [Full Text] [Related]
7. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme. Wang K; Lu Y; Liu Z; Diao M; Yang L Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681 [TBL] [Abstract][Full Text] [Related]
8. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms. Zhang Y; Xia Q; Lin J Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201 [TBL] [Abstract][Full Text] [Related]
9. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related]
12. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats. Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258 [TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma. Zhang Y; Zhang B; Lv C; Zhang N; Xing K; Wang Z; Lv R; Yu M; Xu C; Wang Y Theranostics; 2023; 13(11):3744-3760. PubMed ID: 37441593 [No Abstract] [Full Text] [Related]
14. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells. Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662 [TBL] [Abstract][Full Text] [Related]
15. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
16. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line. Ghiasvand S; Javidi MA; Mohammadian A; Mousavi SA; Shahriari F; Alavian F Life Sci; 2021 Feb; 266():118874. PubMed ID: 33358904 [TBL] [Abstract][Full Text] [Related]
18. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma. Verbovšek U; Motaln H; Rotter A; Atai NA; Gruden K; Van Noorden CJ; Lah TT PLoS One; 2014; 9(10):e111819. PubMed ID: 25356585 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788 [TBL] [Abstract][Full Text] [Related]
20. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]